Search Results for "Alnylam"
Alnylam is committed to providing the healthcare community with balanced, accurate, and high-quality information about our science, therapeutic areas, and products.
More than one search term is recommended to yield the most relevant results. By searching, you confirm that your query is unsolicited.
For more information about our FDA-approved therapies, please see the Full Prescribing Information:
Vutrisiran: Safety Results from HELIOS-B
Standard response letter on vutrisiran and safety information from the HELIOS-B study.
Standard response letter on vutrisiran and safety information from the HELIOS-B study.
Lumasiran: Latex Content
Standard response letter on the latex content of lumasiran vial.
Standard response letter on the latex content of lumasiran vial.
Patisiran: Ocular Adverse Events
Standard response letter on patisiran and ocular adverse events in the APOLLO study.
Standard response letter on patisiran and ocular adverse events in the APOLLO study.
Givosiran: Pancreatitis
Standard response letter on givosiran and the adverse event of pancreatitis.
Standard response letter on givosiran and the adverse event of pancreatitis.
Givosiran: Temperature Excursions
Standard response letter on givosiran and temperature excursions. This letter contains information on product stability when stored under long-term and accelerated conditions.
Standard response letter on givosiran and temperature excursions. This letter contains information on product stability when stored under long-term and accelerated conditions.
Patisiran: Post-Orthotopic Liver Transplant
Standard response letter on patisiran and the open-label phase 3 study evaluating the efficacy, safety and PK of patisiran in patients with hATTR who had polyneuropathy progression post-OLT. Additional summaries of case reports are also included.
Standard response letter on patisiran and the open-label phase 3 study evaluating the efficacy, safety and PK of patisiran in patients with hATTR who had polyneuropathy progression post-OLT. Additional summaries of case reports are also included.
